Literature DB >> 23494653

Conceptual framework for patient-important treatment outcomes for pelvic organ prolapse.

Vivian W Sung1, Rebecca G Rogers, Matthew D Barber, Melissa A Clark.   

Abstract

AIMS: To develop a comprehensive conceptual framework representing the most important outcomes for women seeking treatment for pelvic organ prolapse (POP).
METHODS: Twenty-five women with POP were recruited and participated in four semi-structured focus groups to refine and assess the content validity of a conceptual framework representing patient-important outcomes for POP. Specifically, the focus groups addressed the following three aims: (1) to evaluate the content and appropriateness of domains in our framework; (2) to identify gaps in the framework; and (3) to determine the relative importance of our framework domains from the patient perspective. Sessions were transcribed, coded, and qualitatively and quantitatively analyzed using analytic induction and deductive analysis to identify themes and domains relevant to women with POP.
RESULTS: Our focus groups confirmed the importance of vaginal bulge symptoms (discomfort, bother, and adaptation), and the overarching domains and subdomains of physical (physical function and participation), social (social function, relationships, and sexual function), and mental health (emotional distress, preoccupation, and body image). Patients ranked outcomes in the following order of importance: (1) the resolution of vaginal bulge symptoms, (2) improvement in physical function; (3) improvement in sexual function; (4) improvement in body image perception; and (5) improvement in social function.
CONCLUSIONS: We developed a conceptual framework for patient important outcomes of women seeking treatment for POP. This framework can improve the transparency and interpretation of POP study findings from the patient perspective. Vaginal bulge and its associated discomfort are most important for the definition of POP treatment success from the patient perspective.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  conceptual framework; female; focus group; outcome assessment; pelvic floor; quality of life; uterine prolapse; visceral prolapse

Mesh:

Year:  2013        PMID: 23494653      PMCID: PMC3796042          DOI: 10.1002/nau.22397

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  23 in total

1.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse.

Authors:  Philip Toozs-Hobson; Robert Freeman; Matthew Barber; Christopher Maher; Bernard Haylen; Stavros Athanasiou; Steven Swift; Kristene Whitmore; Gamal Ghoniem; Dirk de Ridder
Journal:  Neurourol Urodyn       Date:  2012-04       Impact factor: 2.696

2.  Conceptual models for health education research and practice.

Authors:  J A Earp; S T Ennett
Journal:  Health Educ Res       Date:  1991-06

3.  EGGS for patient-centered outcomes.

Authors:  Linda Brubaker; Bob Shull
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-12

4.  Response shift and outcome assessment in orthopedic surgery: is there a difference between complete and partial treatment?

Authors:  Joel A Finkelstein; Helen Razmjou; Carolyn E Schwartz
Journal:  J Clin Epidemiol       Date:  2009-08-13       Impact factor: 6.437

Review 5.  Measuring outcomes in urogynecological surgery: "perspective is everything".

Authors:  Candace Y Parker-Autry; Matthew D Barber; Kimberly Kenton; Holly E Richter
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

6.  Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life.

Authors:  J Eric Jelovsek; Matthew D Barber
Journal:  Am J Obstet Gynecol       Date:  2006-05       Impact factor: 8.661

7.  Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ).

Authors:  Matthew D Barber; Zhen Chen; Emily Lukacz; Alayne Markland; Clifford Wai; Linda Brubaker; Ingrid Nygaard; Alison Weidner; Nancy K Janz; Cathie Spino
Journal:  Neurourol Urodyn       Date:  2011-02-22       Impact factor: 2.696

8.  A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse.

Authors:  R G Rogers; D Kammerer-Doak; A Villarreal; K Coates; C Qualls
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

9.  Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective.

Authors: 
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

10.  Defining success after surgery for pelvic organ prolapse.

Authors:  Matthew D Barber; Linda Brubaker; Ingrid Nygaard; Thomas L Wheeler; Joeseph Schaffer; Zhen Chen; Cathie Spino
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

View more
  13 in total

1.  Relationship of postoperative vaginal anatomy and sexual function: a systematic review with meta-analysis.

Authors:  Shunaha Kim-Fine; Danielle D Antosh; Ethan M Balk; Kate V Meriwether; Gregg Kanter; Alexis A Dieter; Mamta M Mamik; Meadow Good; Ruchira Singh; Alexandriah Alas; Mohamed Foda; David D Rahn; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2021-05-14       Impact factor: 2.894

2.  International Urogynecological Consultation: clinical definition of pelvic organ prolapse.

Authors:  Sarah A Collins; Michele O'Shea; Nicola Dykes; Olga Ramm; Autumn Edenfield; Ka Lai Shek; Kim van Delft; Molly Beestrum; Kimberly Kenton
Journal:  Int Urogynecol J       Date:  2021-06-30       Impact factor: 2.894

3.  International Urogynaecology Consultation chapter 1 committee 4: patients' perception of disease burden of pelvic organ prolapse.

Authors:  Dudley Robinson; Lisa T Prodigalidad; Symphorosa Chan; Maurizio Serati; Svjetlana Lozo; Jerry Lowder; Chiara Ghetti; Kathie Hullfish; Suzanne Hagen; Chantal Dumoulin
Journal:  Int Urogynecol J       Date:  2022-01-03       Impact factor: 2.894

4.  Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.

Authors:  Vivian W Sung; Kyle J Wohlrab; Annetta Madsen; Christina Raker
Journal:  Am J Obstet Gynecol       Date:  2016-06-16       Impact factor: 8.661

5.  Quality of life of obstetrics fistula patients before and after surgical repair in the Jimma University Medical Center, Southwest Ethiopia.

Authors:  Tilahun Fufa Debela; Zerihun Asefa Hordofa; Aster Berhe Aregawi; Demisew Amenu Sori
Journal:  BMC Womens Health       Date:  2021-05-21       Impact factor: 2.809

6.  Patient-relevant outcomes: what are we talking about? A scoping review to improve conceptual clarity.

Authors:  Christine Kersting; Malte Kneer; Anne Barzel
Journal:  BMC Health Serv Res       Date:  2020-06-29       Impact factor: 2.655

7.  Female sexuality before and after sacrocolpopexy or vaginal mesh: is vaginal length one of the key factors?

Authors:  Sònia Anglès-Acedo; Cristina Ros-Cerro; Sílvia Escura-Sancho; M José Palau-Pascual; Eduardo Bataller-Sánchez; Montserrat Espuña-Pons; Francisco Carmona-Herrera
Journal:  Int Urogynecol J       Date:  2021-06-01       Impact factor: 2.894

8.  Deciding Our Future: Consensus Conference Summary Report.

Authors:  Nazema Y Siddiqui; Gena C Dunivan; Christopher J Chermansky; Catherine S Bradley
Journal:  Female Pelvic Med Reconstr Surg       Date:  2020-03       Impact factor: 1.913

9.  Sexual Activity and Dyspareunia 1 Year After Surgical Repair of Pelvic Organ Prolapse.

Authors:  Emily S Lukacz; Amaanti Sridhar; Christopher J Chermansky; David D Rahn; Heidi S Harvie; Marie G Gantz; R Edward Varner; Nicole B Korbly; Donna Mazloomdoost
Journal:  Obstet Gynecol       Date:  2020-09       Impact factor: 7.623

10.  A qualitative evidence synthesis using meta-ethnography to understand the experience of living with pelvic organ prolapse.

Authors:  Francine Toye; Jeannine Pearl; Katy Vincent; Karen Barker
Journal:  Int Urogynecol J       Date:  2020-09-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.